We have recently begun an e-campaign that will be made to the European Parliament and Commission to initiate a process of revision of the way priority – and European funding – has been allocated to experimental research.
We have received over 200 replies within the first 24 hours of the campaign, and are seeking to receive 1,000 signatures. Please support our campaign here.
Here is a selection of responses so far:
- It is indeed true that the EU has started to mainly focus on aspects of public health and applied science. To neglect primary, hypothesis-driven research is rather short-sighted, because the results of basic research will be required for any applied science during future decades.
- Additionally, the new programme Horizon 2020 is very much focusing at European matters forgetting about global issues such as global health
- All types of research must be carried out, without an understanding of the basic biology of a pathogen new public health measures will not be developed or understood.
- Given the huge technological advances being made in all areas of biological abd scientific reserach in the post genomic era, it is absolutely vital that we maintain momentum in research by supporting the scientists in the front-line. No more so is this obvious than in the case of antibiotic research, and vector borne diseases, where resistance to antibiotics, insecticides and drugs will wipe out any gains made in disease control. Highquality reserach must run side-by-side with publioc health. It is expensive, no doubt, but to ignore fundamental research risks destroying the priveleged position we are in of finally starting to gain a foothold in tackling tye great diseases of the age.
- Simply, there will be no REAL progress in public health without substantial progress in basic and pure research activities, history teaches us ( not our EC politicians, it would seem!)
- It is important that our colleagues in the Parliament be reminded that most translational research start with the basics and that a balance in wieght of commitment to promoting either is essential to success in Global Health.
- Research in the field of Diseases like Malaria, Tuberculosis and AIDS should be of big interest for the European as well as the worldwide community. Many progresses have been made already and further investigations are strongly needed to add more detailed experimental data so to be able to act at the present moment with a deeper awareness and to find a resolute answer to such global health problems.
- Without pure research into the vectors of disease little more than accepted paradigms will be tested
- Scientific funding should be based on merit and originality. There is a tendency to fund big labs with big names, and this limits the opportunities for younger and/or less powerful scientist.
- Our mission should be to excel in Discovery and Innovation. Application is a bystander. Trying to see impact in everything without fully appreciating the mechanics will surely lead us to adhoc solutions. This kind of approach will keep us in a cycle of spending public money, when actually we are not heading anywhere.
- A balance between pure and applied research is essential as most applied research is based on the knowledge and discoveries made by pure research. Further, it is rare that pure science discoveries are not examined in the light of their potential application to known problems. We would be pursuing medical research half (at least) blind if we did not equally support research into important pure research questions.
Thank you for all those who have supported the campaign so far. If you haven’t, please do so here.
Did you like this? Share it: